TrialThe Lancet. Haematology2017

Image-based ex-vivo drug screening for patients with aggressive haematological malignancies: interim results from a single-arm, open-label, pilot study.

Berend Snijder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.